Jefferies on Savara (NASDAQ: SVRA): 'We remain 90% confident in Molbreevi's US approval by Aug 22, 2026'.The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE